Back
Inovio Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
INO
Sponsored
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Buy
53
INO
Inovio Pharmaceuticals
Last Price:
12.12
Seasonality Move:
12.57%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerInovio Pharmaceuticals Price Quote
$12.12
+0.02 (+0.92%)
(Updated: May 4, 2024 at 6:24 AM ET)
Inovio Pharmaceuticals Key Stats
Buy
53
Inovio Pharmaceuticals (INO)
is a Buy
Day range:
$11.90 - $12.46
52-week range:
$3.89 - $14.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
322.44
P/B ratio:
2.41%
Volume:
296.3K
Avg. volume:
395K
1-year change:
26.2%
Market cap:
$282.8M
Revenue:
$832K
EPS:
$-6.09
How Much Does Inovio Pharmaceuticals Make?
-
How Much Are Inovio Pharmaceuticals's Sales Annually?
INO Revenues are $832K -
How Much Profit Does Inovio Pharmaceuticals's Make A Year?
INO net income is -$135.1M
Is Inovio Pharmaceuticals Growing As A Company?
-
What Is Inovio Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.18% -
What Is Inovio Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Inovio Pharmaceuticals Stock Price Performance
-
Did Inovio Pharmaceuticals Stock Go Up Last Month?
Inovio Pharmaceuticals share price went down by -1.94% last month -
Did INO's Share Price Rise Over The Last Year?
INO share price rose by 26.2% over the past 1 year
What Is Inovio Pharmaceuticals 52-Week High & Low?
-
What Is Inovio Pharmaceuticals’s 52-Week High Share Price?
Inovio Pharmaceuticals has traded as high as $14.75 over the past 52 weeks -
What Is Inovio Pharmaceuticals’s 52-Week Low Share Price?
Inovio Pharmaceuticals has traded as low as $3.89 over the past 52 weeks
Inovio Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Inovio Pharmaceuticals?
-
How Much Debt Does Inovio Pharmaceuticals Have?
Total long term debt quarterly is $16.8M -
How Much Cash Does Inovio Pharmaceuticals Have?
Cash and short term investments quarterly total is $145.3M -
What Is Inovio Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.15
Is Inovio Pharmaceuticals Cash Flow Positive?
-
What Is INO Cash Flow From Operations?
Cash flow from operations (TTM) is -$124.4M -
What Is Inovio Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5M -
What Is Inovio Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $87.4M
Inovio Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
INO return on invested capital is -72.69% -
What Is Inovio Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -55.73% -
What Is INO Return On Equity?
ROE is a measure of profitability and is -79.81%
Inovio Pharmaceuticals Earnings Date & Stock Price
-
What Is Inovio Pharmaceuticals's Stock Price Today?
A single share of INO can be purchased today for 12.10 -
What Is Inovio Pharmaceuticals’s Stock Symbol?
Inovio Pharmaceuticals trades on the nasdaq under the ticker symbol: INO -
When Is Inovio Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Inovio Pharmaceuticals is scheduled on May 13, 2024 -
When Is INO's next ex-dividend date?
Inovio Pharmaceuticals's next ex-dividend date is May 1, 2020 -
How To Buy Inovio Pharmaceuticals Stock?
You can buy Inovio Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Inovio Pharmaceuticals Competitors
-
Who Are Inovio Pharmaceuticals's Competitors?
Below is a list of companies who compete with Inovio Pharmaceuticals or are related in some way:
Inovio Pharmaceuticals Dividend Yield
Data Unavailable
Inovio Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -356.34% |
Revenue: | -17.66% | -70.17% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 19.25 |
Upside from Last Price: | 59.09% |